These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8765433

  • 1. Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs.
    Andersson BS, Sadeghi T, Siciliano MJ, Legerski R, Murray D.
    Cancer Chemother Pharmacol; 1996; 38(5):406-16. PubMed ID: 8765433
    [Abstract] [Full Text] [Related]

  • 2. Constancy of the relative biological effectiveness of 42 MeV (p-->Be+) neutrons among cell lines with different DNA repair proficiencies.
    Britten RA, Murray D.
    Radiat Res; 1997 Oct; 148(4):308-16. PubMed ID: 9339946
    [Abstract] [Full Text] [Related]

  • 3. The importance of the ERCC1/ERCC4[XPF] complex for hypoxic-cell radioresistance does not appear to derive from its participation in the nucleotide excision repair pathway.
    Murray D, Rosenberg E.
    Mutat Res; 1996 Dec 02; 364(3):217-26. PubMed ID: 8960133
    [Abstract] [Full Text] [Related]

  • 4. The role of DNA damage in the resistance of human chronic myeloid leukemia cells to cyclophosphamide analogues.
    Andersson BS, Mroue M, Britten RA, Murray D.
    Cancer Res; 1994 Oct 15; 54(20):5394-400. PubMed ID: 7923171
    [Abstract] [Full Text] [Related]

  • 5. Sensitivity of nucleotide excision repair-deficient human cells to ionizing radiation and cyclophosphamide.
    Murray D, Vallee-Lucic L, Rosenberg E, Andersson B.
    Anticancer Res; 2002 Oct 15; 22(1A):21-6. PubMed ID: 12017289
    [Abstract] [Full Text] [Related]

  • 6. Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents.
    Damia G, Imperatori L, Stefanini M, D'Incalci M.
    Int J Cancer; 1996 Jun 11; 66(6):779-83. PubMed ID: 8647649
    [Abstract] [Full Text] [Related]

  • 7. Comparative toxicity of arsenite metabolites in wild type CHO cells and in cells deficient in excision repair cross-complementing 1 and 2.
    Vahidnia A, Pablo RF, van der Voet GB, van der Straaten RJ, de Wolff FA.
    Toxicol In Vitro; 2008 Sep 11; 22(6):1662-5. PubMed ID: 18602460
    [Abstract] [Full Text] [Related]

  • 8. Nucleotide excision repair impairment by nodularin in CHO cell lines due to ERCC1/XPF inactivation.
    Lankoff A, Sochacki J, Spoof L, Meriluoto J, Wojcik A, Wegierek A, Verschaeve L.
    Toxicol Lett; 2008 Jun 30; 179(2):101-7. PubMed ID: 18514445
    [Abstract] [Full Text] [Related]

  • 9. DNA repair mechanisms are involved in the hypoxia-dependent toxicity of NLCQ-1 (NSC 709257) and its synergistic interaction with alkylating agents.
    Papadopoulou MV, Bloomer WD.
    In Vivo; 2007 Jun 30; 21(2):175-80. PubMed ID: 17436565
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin sensitivity/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups 1 and 3.
    Lee KB, Parker RJ, Bohr V, Cornelison T, Reed E.
    Carcinogenesis; 1993 Oct 30; 14(10):2177-80. PubMed ID: 8222071
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of cyclophosphamide resistance in a human myeloid leukemia cell line.
    Andersson BS, Mroue M, Britten RA, Farquhar D, Murray D.
    Acta Oncol; 1995 Oct 30; 34(2):247-51. PubMed ID: 7718264
    [Abstract] [Full Text] [Related]

  • 12. ERCC1/ERCC4 5'-endonuclease activity as a determinant of hypoxic cell radiosensitivity.
    Murray D, Macann A, Hanson J, Rosenberg E.
    Int J Radiat Biol; 1996 Mar 30; 69(3):319-27. PubMed ID: 8613681
    [Abstract] [Full Text] [Related]

  • 13. Characterization of illudin S sensitivity in DNA repair-deficient Chinese hamster cells. Unusually high sensitivity of ERCC2 and ERCC3 DNA helicase-deficient mutants in comparison to other chemotherapeutic agents.
    Kelner MJ, McMorris TC, Estes L, Rutherford M, Montoya M, Goldstein J, Samson K, Starr R, Taetle R.
    Biochem Pharmacol; 1994 Jul 19; 48(2):403-9. PubMed ID: 8053936
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP does not affect cellular response to oxaliplatin.
    van Huis-Tanja LH, Kweekel DM, Lu X, Franken K, Koopman M, Gelderblom H, Antonini NF, Punt CJ, Guchelaar HJ, van der Straaten T.
    Mutat Res; 2014 Jan 19; 759():37-44. PubMed ID: 24220697
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of human O6-methylguanine-DNA methyltransferase in a DNA excision repair-deficient Chinese hamster ovary cell line and its response to certain alkylating agents.
    Wu ZN, Chan CL, Eastman A, Bresnick E.
    Cancer Res; 1992 Jan 01; 52(1):32-5. PubMed ID: 1727384
    [Abstract] [Full Text] [Related]

  • 19. Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity.
    Cai Y, Wu MH, Ludeman SM, Grdina DJ, Dolan ME.
    Cancer Res; 1999 Jul 01; 59(13):3059-63. PubMed ID: 10397244
    [Abstract] [Full Text] [Related]

  • 20. Involvement of nucleotide excision repair (NER) system in repair of mono ADP-ribosylated dG adducts produced by pierisin-1, a cytotoxic protein from cabbage butterfly.
    Shiotani B, Watanabe M, Totsuka Y, Sugimura T, Wakabayashi K.
    Mutat Res; 2005 May 02; 572(1-2):150-5. PubMed ID: 15790498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.